Viewing StudyNCT05945368



Ignite Creation Date: 2024-05-06 @ 7:15 PM
Last Modification Date: 2024-10-26 @ 3:03 PM
Study NCT ID: NCT05945368
Status: RECRUITING
Last Update Posted: 2023-07-14
First Post: 2023-05-28

Brief Title: A Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BC
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Conditions & Keywords Data

Conditions:
Name
HER2-positive Breast Cancer
Keywords:
Name View
HER 2-positive View
Early or locally advanced breast cancer View